Skip to main content

Media Alert – Investment Announcement!

July 27th 2023 – Birmingham, Michigan – CitySide Ventures and GLAF announce adding UrynX to its portfolio of companies.

UrynX has developed NeU-Cup, a user-friendly and hygienic urine test and collection system that can be used at home. This innovative telemedicine solution revolutionizes urinalysis by seamlessly integrating into any medical practice. Patients can now receive the equivalent of an office visit, including urinalysis tests, through a telemedicine visit from the comfort of their own home.

With the NeU-Cup Telemedicine Kit, patients can easily take a diagnostic urinalysis test and collect a urine sample at home. The NeU-Cup app securely transmits the test results to the doctor via the patient’s cell phone, HIPPA compliant, ensuring privacy and convenience. The physician then reviews the results and initiates a telehealth visit with the patient.

Not only does this provide a more convenient and comfortable experience for patients, but it also generates additional income for medical practices through reimbursement codes for both the diagnostic tests and telehealth visits. Embrace the future of urinalysis with NeU-Cup and unlock the potential of telemedicine in healthcare.

It is not so often that we see a MedTech solution that was invented by Doctors for Doctors. This product is a real innovation that is creating a low cost revenue generator to Urology clinics while increasing patient experience and convenience . Doron York – Chairman/CEO  at CitySide Ventures 

CitySide Ventures is to become a premier Investment group committed to taking Michigan Angel investing to a new level by building a network of active, progressive, and innovative investors committed to turning Michigan into a powerhouse startup ecosystem.

For more information about Birmingham Angels please visit us at

For more information about Great Lakes Angels Fund please visit us at

If you are an accredited investor and would like to schedule a private meeting,

please complete the following request form:

or contact us: or 248. 535.1306